Previous Close | 6.38 |
Open | 6.50 |
Bid | 0.00 x 800 |
Ask | 0.00 x 2900 |
Day's Range | 6.28 - 6.73 |
52 Week Range | 2.87 - 8.58 |
Volume | |
Avg. Volume | 3,781,915 |
Market Cap | 464.811M |
Beta (5Y Monthly) | 1.00 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -9.95 |
Earnings Date | Mar 02, 2023 - Mar 06, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.56 |
The chief executive of bluebird bio's oncology-focused spinout believes that this year, it will take off as a company in its own right.
Every investor in bluebird bio, Inc. ( NASDAQ:BLUE ) should be aware of the most powerful shareholder groups. And the...
bluebird bio, Pros Holdings and Norwegian Cruise Line are part of the Zacks Screen of the Week article.